End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
93.1 TWD | +18.90% | +25.81% | -18.33% |
Apr. 23 | Lin BioScience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Lin BioScience, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Sales 2022 | - | Sales 2023 | - | Capitalization | 8.95B 291B |
---|---|---|---|---|---|
Net income 2022 | -314M -10.23B | Net income 2023 | -687M -22.38B | EV / Sales 2022 | - |
Net cash position 2022 | 1.6B 52.09B | Net cash position 2023 | 3.22B 105B | EV / Sales 2023 | - |
P/E ratio 2022 |
-39.8
x | P/E ratio 2023 |
-12.3
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
1 day | +18.90% | ||
1 week | +25.81% | ||
Current month | +5.80% | ||
1 month | -4.71% | ||
3 months | -11.33% | ||
6 months | -20.77% | ||
Current year | -18.33% |
Managers | Title | Age | Since |
---|---|---|---|
Yue Hsin Lin
FOU | Founder | 46 | 16-05-11 |
Wan Shan Chen
DFI | Director of Finance/CFO | 38 | 16-05-31 |
Hung Wei Chen
COO | Chief Operating Officer | 43 | 16-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hsien Hua Huang
BRD | Director/Board Member | - | 18-09-26 |
San Chien Tu
BRD | Director/Board Member | - | 18-09-26 |
Chan Yue Li
BRD | Director/Board Member | 52 | 16-10-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 117 M€ | +1.11% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 93.1 | +18.90% | 1,103,235 |
24-04-25 | 78.3 | +3.03% | 265,668 |
24-04-24 | 76 | +3.83% | 361,887 |
24-04-23 | 73.2 | +1.67% | 316,648 |
24-04-22 | 72 | -2.70% | 352,877 |
End-of-day quote Taipei Exchange, April 25, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-18.33% | 189M | |
+25.83% | 653B | |
+27.00% | 556B | |
-6.76% | 354B | |
+20.34% | 331B | |
+3.00% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-6.26% | 144B |
- Stock Market
- Equities
- 6696 Stock